Toxicity radiotherapy anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Tumor Cells, Cultured Organs at Risk Cell Line HCT116 Cells HT29 Cells Cells, Cultured

Organisms2

Mice, Nude Mice, Inbred BALB C

Diseases52

Radiation Injuries Neoplasms Radiation Pneumonitis Head and Neck Neoplasms Neoplasms, Radiation-Induced Neoplasm Recurrence, Local Brain Neoplasms Breast Neoplasms Carcinoma, Squamous Cell Lung Neoplasms Radiation Injuries, Experimental Nasopharyngeal Neoplasms Radiodermatitis Adenocarcinoma Prostatic Neoplasms Rectal Neoplasms Carcinoma, Non-Small-Cell Lung Glioblastoma Pelvic Neoplasms Hodgkin Disease Glioma Carcinoma Neoplasms, Second Primary Laryngeal Neoplasms Neoplasm Metastasis Xerostomia Uterine Cervical Neoplasms Neoplasms, Experimental Colonic Neoplasms Spinal Neoplasms Sarcoma Bone Neoplasms Thoracic Neoplasms Stomatitis Esophageal Neoplasms Melanoma Acute Radiation Syndrome Leukemia, Radiation-Induced Liver Neoplasms Pancreatic Neoplasms Osteoradionecrosis Lymphatic Metastasis Mucositis Leukopenia Disease Progression Carcinoma, Small Cell Supratentorial Neoplasms Lymphoma Oropharyngeal Neoplasms Skin Neoplasms Central Nervous System Neoplasms Leukemia P388

Chemicals and Drugs67

Antineoplastic Agents Cisplatin Doxorubicin Radiation-Sensitizing Agents Antineoplastic Agents, Phytogenic Fluorouracil Antibiotics, Antineoplastic Etoposide Radiation-Protective Agents Paclitaxel Vincristine Drug Carriers Camptothecin Antineoplastic Agents, Alkylating Dacarbazine Cobalt Radioisotopes Antimetabolites, Antineoplastic Bleomycin Vinblastine Ellipticines Cyclophosphamide Organoplatinum Compounds Deoxycytidine P-Glycoprotein Prodrugs Carboplatin Procarbazine Mitomycin Nimustine Enzyme Inhibitors Methotrexate Tumor Suppressor Protein p53 Plant Extracts Amifostine Mechlorethamine Daunorubicin Taxoids Platinum Radiopharmaceuticals DNA Topoisomerases, Type II Iridium Radioisotopes Topoisomerase I Inhibitors Proto-Oncogene Proteins c-bcl-2 Mitoxantrone DNA Neoplasm Proteins Caspase 3 Caspases Razoxane Triazines Antibodies, Monoclonal Nanocapsules Androgen Antagonists Lomustine Angiogenesis Inhibitors Tumor Markers, Biological Prednisone Liposomes Reactive Oxygen Species Drugs, Investigational Radioisotopes Teniposide DNA Adducts Multidrug Resistance-Associated Proteins RNA, Small Interfering Chlorambucil Intercalating Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment85

Radiotherapy Radiotherapy Dosage Radiotherapy, Conformal Radiotherapy, Adjuvant Radiation Dosage Dose-Response Relationship, Radiation Combined Modality Therapy Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy, High-Energy Dose Fractionation Radiotherapy, Computer-Assisted Radiotherapy, Image-Guided Drug Screening Assays, Antitumor Treatment Outcome Radiation Monitoring Antineoplastic Combined Chemotherapy Protocols Brachytherapy Toxicity Tests Radiosurgery Radiometry Neoplasm Staging Chemoradiotherapy Disease-Free Survival Radiation Injuries, Experimental Survival Analysis Survival Rate Drug Delivery Systems Retrospective Studies Xenograft Model Antitumor Assays Particle Accelerators Follow-Up Studies Drug Carriers Chemotherapy, Adjuvant Cranial Irradiation Prognosis Drug Administration Schedule Tomography, X-Ray Computed Toxicity Tests, Acute Tumor Burden Inhibitory Concentration 50 Mastectomy, Segmental Clinical Trials as Topic Drug Evaluation, Preclinical Drug Design Neoadjuvant Therapy Neoplasm Transplantation Heavy Ion Radiotherapy Organ Sparing Treatments Neoplasms, Experimental Lethal Dose 50 Radioisotope Teletherapy Lymphatic Irradiation Palliative Care Salvage Therapy Feasibility Studies Kaplan-Meier Estimate Models, Biological Prospective Studies Molecular Targeted Therapy Maximum Tolerated Dose Positron-Emission Tomography Transplantation, Heterologous Mastectomy Blotting, Western Administration, Oral Remission Induction Hyperthermia, Induced Flow Cytometry Clinical Trials, Phase I as Topic Drug Discovery Nanocapsules Proton Therapy Radiation Hybrid Mapping Radiotherapy Setup Errors Whole-Body Irradiation Infusions, Intravenous Drug Evaluation Patient Positioning Immunohistochemistry Actuarial Analysis Tumor Stem Cell Assay Magnetic Resonance Imaging Body Burden Treatment Failure

Phenomena and Processes40

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Apoptosis Cell Survival Drug Resistance, Neoplasm Time Factors Gamma Rays Dose-Response Relationship, Drug DNA Damage Cosmic Radiation Cell Proliferation Background Radiation Ultraviolet Rays Inhibitory Concentration 50 Drug Synergism Molecular Structure Cell Cycle Drug Resistance, Multiple Radiation Effects DNA Repair Gene Expression Regulation, Neoplastic X-Rays Lethal Dose 50 Heavy Ions Cell Death Signal Transduction Maximum Tolerated Dose Linear Energy Transfer Cell Division Tissue Distribution Structure-Activity Relationship Mutation Cell Hypoxia Drug Resistance DNA Adducts Cell Cycle Checkpoints Particle Size

Disciplines and Occupations7

Radiation Oncology Radiobiology Drug Design Nanomedicine Health Physics Drug Discovery Immunohistochemistry

Technology, Industry, Agriculture4

Nanoparticles Nanomedicine Nanocapsules Liposomes

Information Science5

Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy, Computer-Assisted Survival Rate

Health Care29

Radiation Injuries Radiation Dosage Dose-Response Relationship, Radiation Radiation Protection Treatment Outcome Radiation Monitoring Disease-Free Survival Radiation Injuries, Experimental Survival Analysis Survival Rate Retrospective Studies Follow-Up Studies Cosmic Radiation Ultraviolet Rays Radiation Effects Clinical Trials as Topic Palliative Care Feasibility Studies Kaplan-Meier Estimate Relative Biological Effectiveness Prospective Studies Acute Radiation Syndrome Clinical Trials, Phase I as Topic Radioactive Hazard Release Radiotherapy Setup Errors Patient Positioning Actuarial Analysis Body Burden Treatment Failure

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Radiotherapy Radiotherapy Dosage Radiation Injuries Radiotherapy, Conformal Radiotherapy, Adjuvant Antineoplastic Agents Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Combined Modality Therapy Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiation Tolerance Radiotherapy, High-Energy Dose Fractionation Radiation Oncology Neoplasms Cell Line, Tumor Radiation Radiotherapy, Computer-Assisted Radiotherapy, Image-Guided Radiation Protection Cisplatin Drug Screening Assays, Antitumor Doxorubicin Treatment Outcome Radiation Monitoring Antineoplastic Combined Chemotherapy Protocols Radiation-Sensitizing Agents Radiation Pneumonitis Brachytherapy Apoptosis Head and Neck Neoplasms Cell Survival Antineoplastic Agents, Phytogenic Toxicity Tests Radiosurgery Radiometry Neoplasms, Radiation-Induced Neoplasm Recurrence, Local Brain Neoplasms Drug Resistance, Neoplasm Neoplasm Staging Breast Neoplasms Fluorouracil Chemoradiotherapy Carcinoma, Squamous Cell Lung Neoplasms Time Factors Disease-Free Survival Antibiotics, Antineoplastic Gamma Rays Dose-Response Relationship, Drug Radiation Injuries, Experimental Etoposide Survival Analysis Survival Rate Drug Delivery Systems Retrospective Studies Radiation-Protective Agents Mice, Nude Xenograft Model Antitumor Assays Tumor Cells, Cultured Particle Accelerators Paclitaxel Nasopharyngeal Neoplasms Organs at Risk DNA Damage Radiodermatitis Vincristine Follow-Up Studies Drug Carriers Camptothecin Chemotherapy, Adjuvant Cosmic Radiation Cranial Irradiation Adenocarcinoma Prognosis Antineoplastic Agents, Alkylating Prostatic Neoplasms Dacarbazine Cell Proliferation Rectal Neoplasms Cobalt Radioisotopes Drug Administration Schedule Antimetabolites, Antineoplastic Bleomycin Vinblastine Tomography, X-Ray Computed Carcinoma, Non-Small-Cell Lung Toxicity Tests, Acute Ellipticines Background Radiation Tumor Burden Glioblastoma Pelvic Neoplasms Ultraviolet Rays Inhibitory Concentration 50 Hodgkin Disease Glioma

No FAQ available that match "toxicity radiotherapy anticancer drugs or radiation"